Compare · MDLN vs OBLN
MDLN vs OBLN
Side-by-side comparison of Medline Inc. (MDLN) and Obalon Therapeutics, Inc. (OBLN): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both MDLN and OBLN operate in Medical/Dental Instruments (Health Care), so they compete in similar markets.
- MDLN carries a market cap of $52.15B.
- MDLN has hit the wire 4 times in the past 4 weeks while OBLN has been quiet.
- MDLN has more recent analyst coverage (25 ratings vs 0 for OBLN).
- Company
- Medline Inc.
- Obalon Therapeutics, Inc.
- Price
- $39.73+2.44%
- $2.77-14.24%
- Market cap
- $52.15B
- -
- 1M return
- +5.09%
- -
- 1Y return
- -2.52%
- -
- Industry
- Medical/Dental Instruments
- Medical/Dental Instruments
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2025
- 2016
- News (4w)
- 4
- 0
- Recent ratings
- 25
- 0
Latest MDLN
- Medline strengthens California distribution network with new 1 million-square-foot facility in Perris
- Medline Inc. filed SEC Form 8-K: Leadership Update
- Medline announces Prime Vendor agreement with Allina Health
- Securing new 1.6-plus million square feet of new space after fire, Medline leases two large distribution centers in Northern California
- Medline to report second quarter 2026 results on August 5, 2026
- Officer Abrams William J covered exercise/tax liability with 1,308 shares, decreasing direct ownership by 7% to 16,546 units (SEC Form 4)
- Chief Human Resources Officer Shryock Christopher P covered exercise/tax liability with 872 shares, decreasing direct ownership by 7% to 11,031 units (SEC Form 4)
- Chief Operating Officer Miller Stephen L covered exercise/tax liability with 1,889 shares, decreasing direct ownership by 7% to 23,899 units (SEC Form 4)
- Chief Legal Officer Liberman Alexander M. covered exercise/tax liability with 872 shares, decreasing direct ownership by 7% to 11,031 units (SEC Form 4)
- Chief Product Officer Laabs Amanda H. covered exercise/tax liability with 1,889 shares, decreasing direct ownership by 7% to 23,899 units (SEC Form 4)
Latest OBLN
- Obalon Therapeutics, Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits
- SEC Form SC 13G/A filed by Obalon Therapeutics, Inc. (Amendment)
- SEC Form SC 13D/A filed by Obalon Therapeutics, Inc. (Amendment)
- SEC Form 4 filed by ARMISTICE CAPITAL, LLC
- SEC Form SC 13D filed by Obalon Therapeutics, Inc.
- SEC Form 3: STANKOVICH THOMAS claimed ownership of 2,613 units of Common Stock
- SEC Form 3 filed by McDougal Lori Courtney
- SEC Form 3 filed by GLADNEY DAN W
- SEC Form 3 filed by MINOCHERHOMJEE ARDA PHD
- SEC Form 3 filed by Bandy Barton P.